| Date | Title | Description |
| 01.09.2026 | Glooko Launches GestationalCare to Unify Multi-Device Diabetes Telemetry in High-Risk Pregnancy | What You Should Know
Global connected diabetes care leader Glooko, Inc. announced GestationalCare™, a dedicated pregnancy-specific clinical module built on its ambulatory diabetes management platform.
GestationalCare resolves the acute chal... |
| 15.05.2026 | FDA Grants 510(k) Clearance for Glooko’s EndoTool IV Cloud Insulin Dosing Platform | What You Should Know
Glooko has received U.S. FDA 510(k) clearance for EndoTool IV Cloud, making it the first cloud-based, patient-specific insulin dosing platform cleared for hospital use.
The system is the cloud-native evolution of EndoTo... |
| 17.09.2025 | AltrixBio: $5 Million Series A Closed For Developing Cardiometabolic Disease Treatment | AltrixBio has secured $5 million in an initial Series A financing to advance its lead candidate, AJN 003 (LuCI), into human clinical trials for type 2 diabetes and related metabolic diseases. This oral therapy is designed to recreate the me... |
| 18.04.2025 | Caregentic Appoints Russ Johannesson as CEO to Lead Expansion | Russ Johannesson, CEO at Caregentic
What You Should Know:
– Caregentic, an AI-native patient automation platform focused on streamlining clinician workflows, has announced the appointment of Russ Johannesson as its new Chief Executive Offic... |
| 08.01.2025 | Hedia and Glooko Partner to Elevate Diabetes Management with Personalised Bolus Insulin Dosing | New integration delivers personalised insulin dosing advice, improving care for people with diabetes and enhancing healthcare provider insights.
COPENHAGEN, Denmark and PALO ALTO, Calif., Jan. 8, 2025 /PRNewswire/ -- Glooko, Inc. and Hedia,... |
| 15.10.2024 | Glooko: Digital Health Company Raises $100 Million (Series F) | Glooko, a global integrated digital health company connecting patients, providers, biopharma, and medical device partners, announced that it has secured a $100 million Series F funding round. And the company’s Board of Directors also announ... |
| 11.10.2024 | Glooko scores $100M and appoints new CEO | Photo: ViewStock/Getty Images
Glooko, the maker of a digital platform for managing diabetes and other chronic diseases, has secured $100 million in Series F funding and announced Mike Alvarez as the company's newly appointed CEO.
Georgian l... |
| 10.10.2024 | Glooko Raises $100M in Series F Financing | Glooko, Inc., a Palo Alto, CA-based global integrated digital health company connecting patients, providers, biopharma and medical device partners, raised $100m in Series F financing.
The round was led by Georgian, with participation from H... |
| 10.10.2024 | Glooko Secures $100M, Appoints Mike Alvarez as New CEO | – Glooko, a global digital health company, has announced a successful Series F funding round, raising $100M to fuel its continued growth and product development led by Georgian, with participation from Health Catalyst Capital, Canaan, and o... |
| 10.10.2024 | Glooko Raises $100M Series F Round |
PALO ALTO, CA, Glooko today announced that it has secured a $100 million Series F financing.
>> Click here for more funding data on Glooko
>> To export Glooko funding data to PDF and Excel, click here
Glooko, a global integrate... |
| 24.03.2024 | Report: Digital Diabetes Management Tools Fall Short | Digital diabetes management tools fail to provide meaningful clinical benefits and increase health spending, a new report from the Peterson Health Technology Institute (PHTI) shows.
This is PHTI’s inaugural report after launching in July as... |
| 09.01.2024 | Better Therapeutics CEO talks partnership with Glooko | The AspyreRx digital behavioral platform will be made available to Glooko patients
Last week, Better Therapeutics, a company developing prescription digital therapeutics (PDTs) for treating cardiometabolic diseases, and diabetes management ... |
| 12.04.2023 | Glooko integrates with Hedia for personalized insulin dosing | The Hedia Diabetes Assistant provides insulin dosing advice based on each individual's habits
Over 37 million Americans have diabetes, a disease that can have detremental effects on other parts of the body: 69% have high blood pressure, 44%... |
| 05.02.2023 | Expectations For The Connected Care Business In The Years Ahead | Russ Johannesson, CEO at Glooko
Though we seldom see their use in our modern world and, even then, only in fiction, there was a time when it was common for people to actually use things like crystal balls and divining rods to try to uncover... |
| 13.07.2022 | Glooko Launches Diabetes Medical Education Academy in Ireland | What You Should Know:
– Glooko announced, in partnership with the Diabetes Technology Network (DTN)/Association of British Clinical Diabetologists (ABCD), the expansion into Ireland of Academy, the company’s online medical education program... |
| 29.05.2022 | Sharper data collection is key to better insurance CX | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. Register today!
Digital transformation has been one of insurance ... |
| 28.04.2022 | Glooko Appoints Alfonso "Chito" Zulueta, former Eli Lilly & Company Senior Executive, to Board of Directors | PALO ALTO, Calif., April 28, 2022 /PRNewswire/ -- Glooko, Inc., a leading provider of remote patient monitoring and data management solutions for diabetes and related chronic conditions, today announced the appointment of Alfonso "Chit... |
| 30.03.2022 | Terumo and Glooko Announce Collaboration on New Solution for Diabetes Data Sharing | A Technology Integration for MEDISAFE WITHTM Insulin Patch Pump Patients to Upload Data Anytime Anywhere
TOKYO, March 30, 2022 /PRNewswire/ -- Terumo Corporation (TSE: 4543), a global leader in medical technology, and Glooko, a global leade... |
| 16.03.2022 | Day 3 HIMSS Roundup: Glooko Acquires DIABNEXT, GE Healthcare/AliveCor Integration | Venture Capital, Private Equity, Mergers & Acquisitions (M&A) Activity
Glooko Acquires DIABNEXT® to Expand Diabetes Offerings in France
Glooko, a leading provider of remote patient monitoring and data management solutions for diabet... |
| 16.03.2022 | Glooko Acquires DIABNEXT to Expand Diabetes Offerings in France | What You Should Know:
Glooko, a leading provider of remote patient monitoring and data management solutions for diabetes and related chronic conditions, today announced the acquisition of DIABNEXT, a Paris-based company whose digital health... |
| 18.10.2021 | Commercializing Digital Therapeutic Solutions: Key Lessons Learned to Watch | Komathi Stem, Chief Operating Officer at GlookoZach Henderson, Chief Commercial Officer at Glooko
The pandemic has set ablaze the white-hot market for Digital Therapeutics (DTx), which “deliver medical interventions directly to patients usi... |
| 10.08.2021 | HIMSS21 Day 1 News: Google Cloud, Salesforce, Zoom, Philips, GE Healthcare, GoodRx | Google Cloud Unveils New Research examining COVID-19’s Acceleration of Innovation in Healthcare
Google Cloud revealed new research unveiling the impact of COVID-19 on reshaping technology’s role in healthcare. This research is the second ph... |
| 09.08.2021 | Glooko Announces New Chief Technology Officer | |
| 09.08.2021 | Glooko : Announces New Chief Technology Officer | PALO ALTO, Calif., Aug. 9, 2021 /PRNewswire/ -- Glooko Inc., the leading provider of remote patient monitoring and data management platforms in diabetes and related chronic conditions, today announced the appointment of Prakash Menon as the... |
| 06.05.2021 | Glooko Announces Digital Health Collaboration with Eli Lilly's Connected Insulin Pen Solutions in Global Markets | |
| 06.05.2021 | Glooko Integrates with Eli Lilly’s Connected Insulin Pen Solutions in Global Markets | What We Should Know:
– Glooko Inc., a provider of remote patient monitoring and data management solutions for diabetes and other chronic conditions announced a strategic collaboration with Eli Lilly and Company for people with diabetes that... |
| 15.04.2021 | Decentralized Clinical Trials: Surviving & Thriving in the Clinical Research World of COVID-19 | Zach Henderson, Chief Commercial Officer, Glooko
As with so many aspects of our daily lives, the impact of the COVID-19 pandemic on clinical trials was both widespread and monumental. Thousands of trials—an estimated 80% of non-COVID-19 tri... |
| 24.03.2021 | FierceBiotech: Glooko raises $30M to expand digital diabetes efforts | - |
| 17.03.2021 | Diabetes management platform Glooko raises $30M | The company saw 80 percent growth in use of its remote solutions during the pandemic
COVID isn't a disease anyone wants to get, of course, but it's even worse for people with certain comorbidities. That includes diabetes, which affected 34.... |
| 16.03.2021 | Daily funding roundup - March 16th, 2021 | Clarify Health raised $115M; Unite Us landed $150M; SquareSpace secured $300M
Appfire: Appfire is a Burlington, Ma.-based company that has developed domain expertise in creating, launching and distributing apps through the Atlassian Marketp... |
| 16.03.2021 | Glooko Raises $30M to Expand Digital Diabetes Management Platform | What You Should Know:
– Glooko, a Palo Alto, CA-based provider of remote patient monitoring and chronic care management solutions including diabetes and obesity, today announced that they have raised a $30 million Series D round of funding.... |
| 16.03.2021 | Glooko raises $30M to expand digital diabetes efforts | Digital diabetes management developer Glooko has raised $30 million to continue its growth, fueled by rising demands for telehealth programs plus multiple partnerships maintained with health systems and biopharma industry companies over the... |
| 16.03.2021 | Glooko raises $30M to expand digital diabetes efforts | Digital diabetes management developer Glooko has raised $30 million to continue its growth, fueled by rising demands for telehealth programs plus multiple partnerships maintained with health systems and biopharma industry companies over the... |
| 16.03.2021 | Glooko Raises $30 Million Financing Round
USA - English
España - español
Deutschland - Deutsch
France - Français
Sverige - Svenska
USA - English | |
| 16.03.2021 | Glooko Raises $30M Series D Financing |
PALO ALTO, CA, Glooko has raised a $30 million Series D round of funding.
>> Click here for more funding data on Glooko
>> To export Glooko funding data to PDF and Excel, click here
Glooko, a leading provider of remote pa... |
| 22.08.2020 | Launched with $17 million by two former Norwest investors, Tau Ventures is ready for its closeup | Amit Garg and Sanjay Rao have spent the bulk of their professional lives developing technology, founding startups and investing in startups at places like Google and Microsoft, HealthIQ, and Norwest Venture Partners.
Over their decade-long ... |
| 21.12.2018 | За параноиками реально следят, но не так тщательно, как за сахаром в крови. Цифровая терапевтика. Часть вторая | Цифровая таблетка от компании Proteus WSJ
0 Обсудить
388 просмотров
Продолжение. Часть первая.
Представьте, что у вашего собеседника параноидальная шизофрения, и он говорит вам, что за ним следят, с помощью миниатюрного передатчика в его же... |
| 28.05.2018 | New Glooko CEO: Livongo gets a lot of press but our approach is different | In a recent, wide-ranging phone interview on the future of Glooko and his role, Johannesson pushed back on the idea that he is the CEO whose sole goal is to take Glooko to an exit, opined on competitors like Livongo, and painted a picture o... |
| 09.04.2018 | The biotech, digital health VC to know | Julie Papanek Grant, a partner at Silicon Valley healthcare and tech VC firm Canaan Partners, has managed to check both those boxes in the last couple of years. And while she begs off revealing what her biggest mistake has been and what she... |
| 08.03.2018 | Tech pioneers and healthcare incumbents on value-based care models | Both sides discuss how to work together to move forward with value-based care
On March 15, Vator and HP will host its second SplashX Invent Health event, and its first for the 2018 series. See details of the "Future of Clinics" ev... |
| 27.12.2017 | How AI can conquer the last data frontier | While there has been some promising medical device innovation, system-level healthcare innovation is truly lacking. If you walk into your doctor’s office, you will likely see clinicians sitting behind an old computer, typing notes or fillin... |
| 20.09.2017 | Who takes on risk in a value-based care model? | At SplashX, it was discussed how patients and providers can take on some risk in emerging models
Last week, Vator teamed up with HP to hold the SplashX: Invent Health event, where we asked some of the most prominent VCs, entreprenuers and m... |
| 18.09.2017 | Do physicians make less in a value-based care model? | At SplashX, doctors and providers discussed how they are compensated for value based care
Last week, Vator teamed up with HP to hold the SplashX: Invent Health event, where we asked some of the most prominent VCs, entreprenuers and members ... |
| 22.08.2017 | How can the in vitro diagnostics industry tap the growth potential of integrated delivery networks? | Integrated delivery networks (IDNs) provide healthcare across the continuum for a geographic region. Typically, they include hospitals and provider networks and may include skilled nursing or long-term rehab facilities, specialty clinics, a... |
| 07.07.2017 | Diabetes platform mySugr exits to Roche for as much as $100M | mySugr, a popular digital diabetes management platform which emerged from Austria a few years ago, has been acquired by health giant Roche. It now becomes the heart of Roche Diabetes Care’s new patient-centered digital health services. Roch... |
| 28.06.2017 | Diabetes management platform Glooko raises $35 million | Glooko, a startup selling data management healthcare service on top of a device-agnostic platform to make it easier for doctors to remotely monitor patients, has pulled in $35 million Series C funding. It had previously raised $36 million i... |
| 27.06.2017 | Glooko Raises $35M to Expand Diabetes Data Platform Internationally | Glooko, a Mountain View, CA-based provider of diabetes data management has rasied $35 million in Series C funding led by Georgian Partners with participation from Insulet Corporation, Mayo Clinic, Canaan Partners, Social Capital, Medtronic ... |
| 27.06.2017 | Glooko Raises $35M in Series C Funding | Glooko, a Mountain View, CA-based provider of diabetes data management solutions, raised $35m in funding.
The round was led by Georgian Partners, with participation from Insulet Corporation and Mayo Clinic and existing investors Canaan Part... |
| 27.06.2017 | Glooko closes $35M Series C round to ratchet up expansion, data analytics capabilities | Rick Altinger, CEO of Glooko, said it would use the funding to accelerate its clinical solutions investments “that aim to increase medication adherence, provide personalized insights and prompts that drive behavior change for people with di... |
| 27.06.2017 | Term Sheet — Tuesday, June 27 | CORPORATE INNOVATION TOUR
The following is from the latest print edition of Fortune, where I write a regular column about technology and startups called “Boom with a View.”
Paid Content Securing the enterprise without boundaries From ExtraH... |
| 09.12.2016 | Forty-five 2016 digital health mergers and acquisitions | This story has been updated to include several acquisitions that were omitted accidentally, as well as new ones that have broken since it was originally published.
Just like last year, 2016 ended up being a big year for acquisitions. With 4... |
| 28.10.2016 | Digital health deals: Vocera buys Extension, Red Cross-Teladoc and more | San Jose-based Vocera Communications, which offers communications services for hospitals and health systems, has acquired fellow clinical communications company Extension Healthcare for $55 million in an all-cash transaction.The acquisition... |
| 07.10.2016 | 18 digital health exits (mergers, acquisitions, and IPOs) in Q3 2016 | As we reported just a few weeks ago, 2016 has thus far proven to be a pretty big year for mergers and acquisitions, and the third quarter was a nice representation of that trend, with 15 acquisitions, one merger, and two IPOs.
Mergers and A... |
| 17.09.2016 | M&A roundup - week ending 9/17/16 | Glooko merged with Diasend; Salesforce bought gravitytank; Concur acquire Hipmunk
Diabetes monitoring platform Glooko merged with competitor Diasend . No financial terms of the deal were disclosed.
The newly merged companies will continue t... |
| 17.09.2016 | Glooko and Diasend Merge; Raises $8M in Funding | Mountain View, CA-based Glooko and Gothenburg, Sweden-based Diasend have merge into a unified company to create a leading diabetes management platform.
The combined business, which merged under the Glooko name, recently raised $8m in equity... |
| 13.09.2016 | Glooko and Diasend Merge to Deliver the World’s Premier Diabetes Management Platform | Combined business now enables in-clinic and remote diabetes management across 4,000 diabetes health systems, 23 countries and 15 languages worldwide
MOUNTAIN VIEW, Calif. & GOTHENBURG, Sweden–(BUSINESS WIRE)–September 13, 2016–
For peop... |
| 13.09.2016 | Glooko and Diasend merge to support international expansion strategy | Rick Altinger, Glooko’s CEO, will serve as CEO of the merged organization. Anders Sonesson, Diasend’s CEO, will manage global operations for Glooko. Diasend is headquartered in Gothenberg, Sweden and Glooko is based in Mountain View, Califo... |
| 13.09.2016 | Glooko, Diasend Merge to Create International Diabetes Management Platform | Diabetes management platform companies Diasend and Glooko announced that it will merge into one company under the Glooko name to deliver the world’s premier diabetes management platform focused on making diabetes management easier for peopl... |
| 13.09.2016 | Glooko merges with Diasend to tackle diabetes globally | The company will still be called Glooko, with CEO Rick Altinger remaining in charge
Most people probably think of diabetes as a problem in the United States, but it's becoming a problem all around the world. The percent adults over 18 years... |
| 12.09.2016 | Details scant, but Verily-Sanofi’s $500M diabetes JV aims to change behavior | However, what exactly the platform is and what products will emerge from this new company based in Cambridge, Massachusetts, is far from crystal clear.
Apparently even to the executives involved.
“The reality is that we don’t have a product... |
| 12.09.2016 | Glooko and Diasend merge to create global diabetes management platform; raise $8M | Two diabetes management companies, Mountain View, California-based Glooko and Gothenburg, Sweden-based Diasend, will merge into a unified company, leveraging the global capabilities of Diasend and the user-friendly platform of Glooko.
The j... |
| 26.05.2016 | Medtronic allies with Qualcomm Life in quest for continuous glucose monitoring with smaller design, better data | The device bigwig also has diabetes-centric partnership with IBM Watson Health, and has invested in start-ups Dreamed Diabetes and Glooko.
“We believe that glucose should be a vital sign of diabetes health. Professional CGM is an increasing... |
| 24.03.2016 | Glooko, Propeller Health, Enlitic on telemedicine trends | At Vator Splash Health 2016, Vator's Roman Arzhintar leads talk on patient-engagement
At Vator Splash Health 2016, Roman Arzhintar (Managing Director, Vator Investment Club) moderated the panel: "Telemedicine and Patient-Engagement&quo... |
| 05.01.2016 | Investors bet big on apps that promise to improve health — and cut costs | OAKLAND, Calif. — A surge in venture funding for startups working on health apps has sparked a flurry of interest in smartphone tools that help doctors diagnose, monitor, and treat patients from afar.
Venture funding for the industry held s... |
| 28.12.2015 | Healthcare deals I’d like to see in 2016: Uber, Under Armour and the Philadelphia 76ers | The wide speculation is that 2016 will be a year in which consolidation will accelerate.
The speculation is correct.
IBM Watson Health acquires Flatiron Health
IBM is one hungry big data kahuna. In the past year, it acquired Cleveland Clini... |
| 04.06.2015 | Medtronic highlights evolving diabetes strategy, Astellas pairs with Swiss biotech in $760M deal (Morning Read) | Japanese drugmaker Astellas and a Swiss biotech startup Anokion are teaming up to launch a joint venture promising up to $760 million with an option to buy the new company. The new venture, Kanyos Bio, will focus on autoimmune disease, usin... |
| 04.06.2015 | Diabetes Management App One Drop Gets $8 Million In Series A Funding To Build Out The Platform | One Drop, an app for diabetes management, has raised $8 million in Series A funding led by RRE, with participation from Box Group, Capital Factory and existing investors LAUNCH and Neu Ventures. The funding will help One Drop to develop the... |
| 23.04.2015 | Report: Mobile health app companies raised $220 million in Q1 | Glooko, which received FDA clearance for a mobile diabetes management app and a metersync device, raised $16.5 million from Medtronic, Canaan Partners, The Social + Capital Partnership and Samsung’s venture investment arm. The funding will ... |
| 21.04.2015 | Razorfish’s Jeff Dachis Launches One Drop, An App For Diabetics To Log And Share Info With Each Other | Co-founder of digital marketing agency Razorfish Jeff Dachis has a new app for diabetes called One Drop, which just launched in the App Store today.
Dachis has always been a health-minded individual. He eats well, works out and runs maratho... |
| 20.03.2015 | Funding roundup - week ending 3/20/15 | InsideSales, Conversa Health, Glooko, Health Catalyst, Shuddle, Clearpath, GelSight, 1Mainstream
(Come mingle with hundreds of top venture capitalists representing $10B-plus in capital under management, including Khosla Ventures, Greylock a... |
| 17.03.2015 | Diabetes monitoring platform Glooko raises $16.5M | Glooko is application that is designed to improve health outcomes for people with diabetes
(Come mingle with hundreds of top venture capitalists representing $10B-plus in capital under management, including Khosla Ventures, Greylock and Jav... |
| 17.03.2015 | Glooko Raises $16.5M in Series B Funding | Glooko Inc., a Palo Alto, Calif.-based platform for diabetes management, raised $16.5m in Series B funding.
The round was co-led by Canaan Partners and Medtronic with participation from existing investors The Social + Capital Partnership an... |
| 17.03.2015 | Glooko Gets $16.5M Injection For Its Diabetes Management Platform | Diabetes management startup Glooko, which sells a unified diabetes data management healthcare service, which includes Bluetooth-enabled hardware to import blood glucose readings from a range of (proprietary) glucose meters to make it easier... |
| 17.03.2015 | Glooko gets $16.5 million from Canaan Partners, Medtronic | Diabetes management platform Glooko has raised $16.5 million in a round led by Canaan Partners. The round also included a strategic investment from Medtronic as well as funding from additional investors The Social+Capital Partnership and Sa... |
| 17.03.2015 | Glooko adds Medtronic as investor in $16.5M Series B | Wende Hutton, general partner at Canaan Partners, will also take a seat on Glooko’s board of directors. She sees the company’s platform as a response to the ACA demands of improving patient care without increasing costs. “Companies that are... |
| 30.01.2015 | Diabeto wants to add cute factor to blood-glucose monitoring for diabetes | Diabeto has done pretty well with the campaign. After 11 days it has secured $14,984, quite a bit more than its $10,000 goal to raise enough funding to position itself for FDA approval in the U.S.. The funding is also intended to support pr... |
| 13.06.2014 | Joslin executive director: Mobile health apps are the future | “We see that the future is with mobile apps. They will boost efficient reporting and make physicians more efficient.” Still, these tools pose their own sets of challenges.
“There are a number of mobile apps that can use our expertise. There... |
| 09.01.2014 | Glooko raises $7M to help people track their diabetes | Glooko supplies a cable and a mobile app, which allows for glucose data to be easily monitored
There are a number of connected and wearable devices that are meant to track a person's health, with companies like JawBone, Nike, Adidas and Und... |
| 08.01.2014 | Glooko Raises $7M in Series A-1 Funding | Glooko Inc., a Palo Alto, CA-based maker of a FDA-cleared mobile diabetes management system, raised $7m in a Series A-1 round.
Backers included new investors including Samsung Venture Investment Company (SVIC) and Lifeforce Ventures as well... |
| 08.01.2014 | Glooko Raises $7M A-1 Funding Round |
PALO ALTO, CA, Glooko, a company developing an FDA-cleared mobile diabetes management system, has raised $7 million in Series A-1 funding.
>> Click here for more funding data on Glooko
>> To export Glooko funding data to PDF... |
| 08.01.2014 | After Arriving On Android, Glooko Lands $7M From Samsung & More To Bring Predictive Diabetes Care Global | The proliferation of connected devices, coupled with rapid advances in data analytics and sensor technology, has fundamentally changed the way people interact with and manage their health. Thanks to smartphones and a new generation of smart... |
| 04.11.2013 | The Dario, Yet Another Smartphone Blood Glucose Monitor, Plans iOS App Launch | The numbers of portable blood glucose monitors linked to smartphones are exploding, given that there are some 26 million diabetics in the U.S. alone and hundreds of millions globally. Glooko is a startup in this space. It helps diabetics to... |
| 29.10.2013 | FDA clears Glooko’s mobile diabetes management system for Android | According to the company:
Using Glooko’s mobile application, these devices can currently download glucose data from dozens of compatible meters, including but not limited to Roche’s ACCU-CHEK Aviva (Black), Abbott’s FreeStyle Lite, and Life... |
| 12.06.2013 | Chamath Palihapitiya Wants to Rewire the Crap Out of Healthcare | Share Share on Facebook Share on Twitter LinkedIn Email Reprints
What does an ex-Facebook tycoon with a degree in electrical engineering know about fixing the U.S. healthcare system?
Well, Chamath Palihapitiya knows that healthcare is in ne... |
| 17.01.2013 | Glooko Receives FDA Clearance For Its Mobile Diabetes Tracker, Hires Intuit Health Exec As Its First CEO | Back in September, Glooko announced the release of a new version of its iOS app, a digital logbook which helps people with diabetes track their blood glucose levels from their smartphone. The new app brought support for six additional gluco... |
| 02.01.2013 | The Ultimate Guide To The 50+ Hottest Health And Fitness Apps, Gadgets And Startups Of The Year | The holidays wreak havoc on our bodies, with their mandatory over-indulgence in food as well as family and reminiscences. As we reflect on the year past — its victories and losses — we also begin looking ahead to the next, and in big ways o... |
| 25.09.2012 | Managing Diabetes With Your iPhone: Glooko Now Supports 17 Different Glucose Meters | According to the Center for Disease Control, 25.8 million Americans (or 8.3 percent of the population) have diabetes, while an estimated 79 million people (aged 20 and older) have prediabetes — making it one of the most pervasive diseases i... |
| 11.07.2012 | Three mobile technologies transforming diabetes management | Managing chronic diseases like diabetes is a priority to lower overall healthcare costs. Now there are 21st Century tools that have the potential to transform how this debilitating disease can be contained.
A new report by a national health... |
| 31.01.2012 | Glooko Raises $3.5M in Series A Funding | Glooko, a Palo Alto, CA-based Mobile diabetes-management company, has raised $3.5m in Series A funding.
Backers reportedly include Bill Campbell, Vint Cerf, Judy Estrin, Andy Hertzfeld and Chamath Palihapitiya’s Social+Capital Partnership.
... |
| 30.01.2012 | Glooko Raises $3.5M To Connect Glucose Meters To iPhones For Tracking Diabetes | Glooko, the developer of a unique hardware device and mobile app solution for people with diabetes, has raised $3.5 million in Series A funding led by The Social+Capital Partnership, with participation from existing investors, including Bil... |
| 30.01.2012 | Glooko nabs $3.5M for diabetes tracking device | The mobile application that automatically logs glucose levels gains strength in mobile health market
For those living with diabetes, keeping on top of their health in the easiest way possible is key. A company called Glooko is working to ma... |
| 30.01.2012 | Glooko raises $3.5M to sync diabetes glucose meters to iPhone app | Did you miss a session from GamesBeat Summit 2022? All sessions are available to stream now. Learn more.
Glooko has raised $3.5 million in a new round of funding that will enable it to release new versions of its solution to help people wit... |
| 09.11.2011 | Glooko Connects Glucose Meters To iPhones For Tracking Diabetes | The iPhone in your pocket can do a lot more than just play games or music. Used properly, that computer can help save your life. Consumer health apps are increasingly hitting iTunes. The latest one to appear today is Glooko (iTunes).
Glooko... |
| - | Glooko closes $35M Series C round to ratchet up expansion, data analytics capabilities | Diabetes management software developer Glooko has closed a $35 million Series C round, adding Mayo Clinic and other new investors. Glooko’s goal with the new funding is to deepen expertise in data analytics and continue to fuel commercializ... |
| - | Medtronic allies with Qualcomm Life in quest for continuous glucose monitoring with smaller design, better data | Medtronic allied with tech titan Qualcomm Life on the development of next-generation continuous glucose monitors, yet another sign that diabetes is one of med tech’s most fertile therapeutic areas for innovation.
The companies said they aim... |
| - | Details scant, but Verily-Sanofi’s $500M diabetes JV aims to change behavior | $248 million in cash from Sanofi, and the same amount in a capital contribution by Verily (not in cash) have breathed life to a new company — Onduo — where the two equal partners will wage battle with a formidable enemy: diabetes.
That part... |
| - | New Glooko CEO: Livongo gets a lot of press but our approach is different | Russ Johannesson, CEO of Glooko
Glooko, the diabetes data management company that has been slowly traversing the path from a digital health startup to one with clinically-validated, FDA-cleared solutions, announced a new CEO on April 10.
Ru... |
| - | Diabeto wants to add cute factor to blood-glucose monitoring for diabetes | Several companies, most notably Glooko and Dexcom have developed different approaches to de-siloing diabetics’ blood-glucose level readings from glucose meters to mobile devices to make it easier for patients and their loved ones to track t... |
| - | FDA clears Glooko’s mobile diabetes management system for Android | Glooko, Inc. received an FDA nod for its Android compatible version of its next-generation diabetes management system. According to a company statement, this system is now “the only FDA-cleared mobile diabetes management system that support... |
| - | Glooko adds Medtronic as investor in $16.5M Series B | Glooko, a digital health company that helps users unlock data from their glucose meter and wearables to better manage patients, has raised a Series B round led by Medtronic and Canaan Partners. The Social + Capital Partnership and Samsung’s... |
